News | July 05, 2025
European Commission fines Alchem for participating in API cartel
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
Opaganib has shown potential in enhancing ARPI treatment by blocking multiple enzymes involved in cancer cell survival.
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
The company also announced results for the third quarter, reporting sales at Rs. 992 crore, flat versus year ago
IGI recently completed the dose-escalation portion of its Phase 1 clinical study in patients with heavily pretreated multiple myeloma
The transaction enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
Bayer expects 2025 to be the most difficult year of its turnaround
A new weapon in the global fight against malaria
The discontinuation decision is only on the basis of commercial reasons and is not due to efficacy or safety reasons
Subscribe To Our Newsletter & Stay Updated
